SCHEMBL7306335

SCHEMBL7306335

Cc1ccc(C2=CCN(C(=O)CCCn3c(=O)[nH]c(=O)c4ccccc43)CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.56
USP2 O75604 3/20 0.56
KDM4E B2RXH2 2/20 0.56
ALDH1A1 P00352 2/20 0.56
ALOX15 P16050 2/20 0.56
TSHR P16473 2/20 0.56
HTT P42858 1/20 0.56
MAPT P10636 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
HPGD P15428 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
PARP1 P09874 10/20 0.49
PARP2 Q9UGN5 1/20 0.49
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
NAMPT P43490 1/20 0.45
TNKS O95271 1/20 0.44
TP53 P04637 1/20 0.43
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7298835 0.92 KDM4E (0.53) HSD17B10USP2KDM4EALDH1A1ALOX15
SCHEMBL7299748 0.83 PARP1 (0.63) PARP1
SCHEMBL7310452 0.83 ALDH1A1 (0.58) HSD17B10USP2KDM4EALDH1A1ALOX15
SCHEMBL7305161 0.76 PARP1 (0.73) PARP1
SCHEMBL7308372 0.76 AR (0.57) HSD17B10USP2ALDH1A1ALOX15TSHR
SCHEMBL7302783 0.75 MAPT (0.70) HSD17B10USP2KDM4EALDH1A1TSHR
SCHEMBL7307433 0.75 PARP1 (0.62) PARP1
SCHEMBL7300140 0.72 FABP4 (0.68) HSD17B10KDM4EALDH1A1TSHRHPGD
SCHEMBL7308089 0.71 TNF (0.62) HSD17B10KDM4EMAPTPARP1LMNA
SCHEMBL20248212 0.70 ALDH1A1 (0.60) HSD17B10USP2KDM4EALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed